Insider Trading April 23, 2026 06:22 PM

Arista Networks CEO Executes $15.8 Million Stock Sale via Pre-Arranged Trading Plan

Jayshree Ullal disposes of over 93,000 shares through various trusts as the company prepares for upcoming earnings reporting.

By Priya Menon ANET
Arista Networks CEO Executes $15.8 Million Stock Sale via Pre-Arranged Trading Plan
ANET

Jayshree Ullal, serving as both CEO and Chairperson of Arista Networks, Inc. (NASDAQ:ANET), has completed the sale of approximately $15.8 million worth of common stock. The transactions, which took place on April 21, 2026, involved a total of 93,861 shares sold at prices ranging from $167.6403 to $170.5066 per share. These sales were conducted indirectly through various trusts and were executed under Rule 10b5-1 trading plans that had been established on November 14, 2025. The divestment occurs while the company's stock is performing strongly, trading near its 52-week high of $178.48 and reflecting a 144% return over the previous year.

Key Points

  • CEO Jayshree Ullal sold $15.8 million in stock through pre-established 10b5-1 plans.
  • Arista Networks is heavily positioned in the AI networking market with significant revenue targets for fiscal 2026.
  • The stock is trading near its 52-week high with a P/E ratio of 62.59, raising questions about relative valuation.

Arista Networks, Inc. (NASDAQ:ANET) has seen significant insider activity following the disposal of common stock by its top leadership. On April 21, 2026, Jayshree Ullal, the company's CEO and Chairperson, executed a series of transactions resulting in the sale of approximately $15.8 million in company shares. These sales were not individual market orders but were part of a structured approach via Rule 10b5-1 trading plans, which were originally set up on November 14, 2025.

The total volume of the sale reached 93,861 shares of Arista Networks common stock. The pricing for these transactions fluctuated between a low of $167.6403 and a high of $170.5066 per share. Notably, these disposals were handled indirectly through multiple trusts. Ms. Ullal serves as a trustee for trusts established for the benefit of her children, and she also acts as a co-trustee for a family trust. While she maintains voting and investment control over these specific shares, she has disclaimed beneficial ownership regarding the holdings in trust for her nephew and niece, as well as the shares held for her children.


Current Holdings Post-Transaction

Following the completion of these sales, Ms. Ullal maintains a substantial interest in Arista Networks through various indirect and direct holdings. Her remaining indirect holdings consist of:

  • 5,273,207 shares held in trusts for her children
  • 17,782,010 shares held by a family trust
  • 30,000 shares held in a trust for her nephew
  • 30,000 shares held in a trust for her niece

Additionally, she maintains a direct holding of 9,917 shares of common stock.


Market Context and Analyst Outlook

The timing of this insider sale coincides with a period of high valuation for the company. Arista Networks' stock has seen a 144% return over the past year and is currently trading near its 52-week high of $178.48. However, analysis from InvestingPro suggests the stock may be overvalued relative to its fair value, noting a P/E ratio of 62.59.

As the company approaches its next earnings report on May 5, market analysts are closely monitoring performance indicators. Evercore ISI has projected revenue at $2.61 billion with an earnings per share of $0.81, driven by enterprise traction and demand for AI technologies. Evercore ISI also reiterated its Outperform rating, pointing toward an increased fiscal 2026 AI revenue target of $3.25 billion, supported by the 7800R4 router and strong overall demand.

Other financial institutions have shared varying degrees of optimism regarding Arista's strategic direction:

  • Rosenblatt: Upgraded the stock from Neutral to Buy with a price target of $180, citing confidence in AI strategy and partnerships with Anthropic and Google.
  • Truist Securities: Initiated coverage with a Buy rating and a $161 price target, highlighting the company's role in the growth of AI networking.
  • Susquehanna: Maintained a Positive rating with a $160 price target.

Key Points and Economic Impact

  • Structured Insider Divestment: The use of Rule 10b5-1 plans indicates that these sales were scheduled well in advance, specifically since November 2025, providing a predictable framework for the transactions.
  • AI-Driven Growth Trajectory: Much of the current valuation and analyst optimism is tied to Arista's positioning within the AI infrastructure sector, specifically through products like the 7800R4 router and partnerships with major AI players.
  • Market Sector Influence: These activities reflect broader trends in the technology and networking sectors, where capital flows are heavily dictated by the scaling of artificial intelligence capabilities and enterprise data center requirements.

Risks and Uncertainties

  • Valuation Risks: With a P/E ratio of 62.59, there is an explicit concern regarding whether the stock is trading at a premium relative to its fair value, which could impact the technology sector if corrections occur.
  • Execution of AI Projections: The company's ability to meet its increased fiscal 2026 AI revenue target of $3.25 billion remains a critical factor for future stability.
  • Sector-Wide Volatility: As Arista is a key player in AI networking, any shifts in the demand from major partners like Google or Anthropic could create volatility within the broader hardware and networking markets.

Risks

  • Potential overvaluation based on current P/E ratios affecting the tech sector.
  • Dependence on meeting high AI-driven revenue targets for fiscal 2026.
  • Market sensitivity to shifts in AI infrastructure demand and major partnerships.

More from Insider Trading

Phibro Animal Health CEO Jack Bendheim Executes $1.16 Million Stock Sale via Pre-Arranged Plan Apr 23, 2026 Prelude Therapeutics Director David P. Bonita Executes $12.5 Million Stock Acquisition Apr 23, 2026 OrbiMed Entities Execute $12.5 Million Stock Acquisition in Prelude Therapeutics Apr 23, 2026 Everpure Executive Executes $12 Million Share Sale Under Pre-Planned Trading Schedule Apr 23, 2026 Insider Activity at The Joint Corp: 10% Owner Charles Jobson Expands Equity Position Apr 23, 2026